<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire: Licensing/Marketing Agreements</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire: Licensing/Marketing Agreements</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products</title>
				<description>IRVINE, California, November 18 /PRNewswire/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and
Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that
Lyon,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4018</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4018</guid>
				<pubDate>Wed, 18 Nov 2009 20:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries</title>
				<description>HAYWARD, California, November 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today
announced that its readerless CD4 point-of-care (POC) technology was selected
by...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3998</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3998</guid>
				<pubDate>Tue, 17 Nov 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health</title>
				<description>PETERSBURG, Virginia, November 4 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: STSI) announced today that the company
plans to introduce the CigRx(TM) nutraceutical product developed by...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3933</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3933</guid>
				<pubDate>Wed, 04 Nov 2009 19:56:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Starts Development LPLChip(TM) With Progenika</title>
				<description>AMSTERDAM, October 29 /PRNewswire/ -- Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced
today that the companies have entered into a development and
commercialization agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3889</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3889</guid>
				<pubDate>Thu, 29 Oct 2009 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein</title>
				<description>BAD HOMBURG, Germany and LACHEN, Switzerland, October 28 /PRNewswire/ -- Octapharma Group and Fresenius Kabi have signed a License, Development
and Supply Agreement regarding the use of Fresenius...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3886</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3886</guid>
				<pubDate>Wed, 28 Oct 2009 18:24:00 +0000</pubDate>
			</item>
					<item>
				<title>Jordan Unveils State of the Art Healthcare Technology in Hospital Trial</title>
				<description>AMMAN, Jordan, October 27 /PRNewswire/ -- The Hashemite Kingdom of Jordan, in a public demonstration today hosted
by His Majesty King Abdullah II, provided a stunning look at the new
integrated...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3880</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3880</guid>
				<pubDate>Tue, 27 Oct 2009 18:31:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA</title>
				<description>CAMBRIDGE, Massachusetts, October 21 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces plans to file a Biologics License
Application (BLA)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3842</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3842</guid>
				<pubDate>Wed, 21 Oct 2009 12:06:00 +0000</pubDate>
			</item>
					<item>
				<title>Thermo Fisher Scientific&#039;s Biomarker B-R-A-H-M-S PCT (Procalcitonin) Included in S3 Guidelines</title>
				<description>HENNIGSDORF, Germany, October 19 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving
science, today announced that its biomarker, B-R-A-H-M-S PCT (procalcitonin),
has been...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3823</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3823</guid>
				<pubDate>Mon, 19 Oct 2009 16:42:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)</title>
				<description>PHILADELPHIA, October 13 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that it has settled all pending
litigation with Sandoz, Inc....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3803</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3803</guid>
				<pubDate>Tue, 13 Oct 2009 17:03:00 +0000</pubDate>
			</item>
					<item>
				<title>The Queensland Facility for Advanced Bioinformatics Selects IPA in Multi-Year Deal for Systems Biology Effort</title>
				<description>REDWOOD CITY, California, October 6 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, and Millennium Science, Ingenuity Systems&#039;...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3765</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3765</guid>
				<pubDate>Tue, 06 Oct 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Onglyza(R) (saxagliptin) Receives Marketing Authorisation in Europe for the Treatment of Type 2 Diabetes</title>
				<description>PARIS and LONDON, October 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN)
(LSE: AZN) announced today that the European Commission has granted...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3757</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3757</guid>
				<pubDate>Mon, 05 Oct 2009 15:55:00 +0000</pubDate>
			</item>
					<item>
				<title>Sanofi Aventis : Multaq(R) (dronedarone) Recommended for Approval in the European Union</title>
				<description>PARIS, September 25 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
that the Committee for Medicinal Products for Human Use (CHMP) of the
European Medicines Agency (EMEA)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3720</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3720</guid>
				<pubDate>Fri, 25 Sep 2009 17:09:00 +0000</pubDate>
			</item>
					<item>
				<title>Afinitor(R) (everolimus) Now Licensed in UK for Advanced Kidney Cancer Patients After Failure of First Line Vascular Targeted Therapy (1,2)</title>
				<description>FRIMLEY, England, September 24 /PRNewswire/ -- Afinitor(R) (everolimus) has recently been licensed for the treatment of 
advanced kidney cancer after failure of treatments which prevent the growth...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3713</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3713</guid>
				<pubDate>Thu, 24 Sep 2009 16:35:00 +0000</pubDate>
			</item>
					<item>
				<title>Novasep Gains SafeBridge(R) &quot;Potent Compound Safety Certification&quot; for its Le Mans Facility</title>
				<description>POMPEY, France, September 17 /PRNewswire/ -- Novasep is pleased to announce that its site in Le Mans -
France, specialized in the development and manufacturing of Highly Potent
Active Pharmaceutical...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3665</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3665</guid>
				<pubDate>Thu, 17 Sep 2009 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.</title>
				<description>FREISING-WEIHENSTEPHAN, Germany, September 15 /PRNewswire/ -- Pieris AG today announced that they have entered into a collaboration
agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris&#039;...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3639</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3639</guid>
				<pubDate>Tue, 15 Sep 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis Patients</title>
				<description>LONDON, September 15 /PRNewswire/ -- Forest Laboratories UK Ltd, (a wholly owned subsidiary of Forest 
Laboratories Inc) announced that following the successful completion of its 
pan-European...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3634</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3634</guid>
				<pubDate>Tue, 15 Sep 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Accumetrics, Inc. Forms Partnership With Grifols as Its Distributor in Spain, Portugal and Chile</title>
				<description>SAN DIEGO, September 2 /PRNewswire/ -- Accumetrics, Inc. has announced the signing of a new exclusive
distribution agreement for its VerifyNow(R) System in Spain, Portugal and
Chile with Grifols...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3567</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3567</guid>
				<pubDate>Wed, 02 Sep 2009 13:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Wyeth&#039;s Torisel Approved by European Commission for the Treatment of Relapsed and/or Refractory Mantle Cell Lymphoma</title>
				<description>MAIDENHEAD, England, August 27 /PRNewswire/ -- Wyeth Europa Ltd., a division of Wyeth (NYSE: WYE), announced today that
the European Commission has approved the mTOR (mammalian target of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3519</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3519</guid>
				<pubDate>Thu, 27 Aug 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity&#039;s Technology Powers BD Cell Pathways Tool on New BD Biosciences Website</title>
				<description>REDWOOD CITY, California, August 11 /PRNewswire/ -- Ingenuity Systems today announced that BD Biosciences, a segment of BD
(Becton, Dickinson and Company), is integrating Ingenuity&#039;s Knowledge...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3456</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3456</guid>
				<pubDate>Tue, 11 Aug 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University</title>
				<description>PALO ALTO, California, August 4 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a biotechnology company developing
antiviral therapies, announced today that it has licensed the exclusive
worldwide...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3437</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3437</guid>
				<pubDate>Tue, 04 Aug 2009 13:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK</title>
				<description>COPENHAGEN, Denmark, July 28 /PRNewswire/ -- Nuevolution today announced the execution of a worldwide
technology cross-licensing agreement with GlaxoSmithKline.

    The agreement relates to a number...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3417</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3417</guid>
				<pubDate>Tue, 28 Jul 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cellestis Appoints BioChemMack as New Commercial Partner in Russia</title>
				<description>MOSCOW, July 23 /PRNewswire/ -- Cellestis is pleased to introduce BioChemMack (Moscow, Russia) as its
newly appointed commercial partner for distribution of the tuberculosis blood
test,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3401</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3401</guid>
				<pubDate>Thu, 23 Jul 2009 08:19:00 +0000</pubDate>
			</item>
					<item>
				<title>BRAHMS KRYPTOR Compact is Certified by the Fetal Medicine Foundation (FMF)</title>
				<description>HENNIGSDORF, Germany, July 17 /PRNewswire/ -- The Fetal Medicine Foundation (FMF) confirmed that BRAHMS KRYPTOR compact
is fulfilling the requirements for first trimester biochemical screening.

   ...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3387</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3387</guid>
				<pubDate>Fri, 17 Jul 2009 15:43:00 +0000</pubDate>
			</item>
					<item>
				<title>Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.</title>
				<description>PORTON DOWN, England, July 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular
diagnostics company, announced today that it has signed two patent...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3383</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3383</guid>
				<pubDate>Thu, 16 Jul 2009 15:53:00 +0000</pubDate>
			</item>
					<item>
				<title>Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test</title>
				<description>LAKE ZURICH, Illinois, July 14 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving
blood collection, separation, safety and availability, announced today it...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3369</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3369</guid>
				<pubDate>Tue, 14 Jul 2009 17:45:00 +0000</pubDate>
			</item>
					<item>
				<title>Sigma-tau Submits Marketing Authorization Application to EMEA for a Novel Anti-Malarial</title>
				<description>ROME, July 6 /PRNewswire/ -- Sigma-tau Industrie Farmaceutiche Riunite S.p.A. (sigma-tau) has 
announced the submission of a centralized Marketing Authorization Application 
(MAA) to the European...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3329</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3329</guid>
				<pubDate>Mon, 06 Jul 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New York City&#039;s World Product Centre Announces Initial Charter Partners</title>
				<description>NEW YORK, July 1 /PRNewswire/ -- World Product Centre (WPC) today announced that Dublin, Ohio-based
Cardinal Health -- one of the world&#039;s largest healthcare suppliers -- is
among the first 11...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3317</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3317</guid>
				<pubDate>Wed, 01 Jul 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen</title>
				<description>CASTRES, France, June 26 /PRNewswire/ -- Laboratoires Pierre Fabre announce today that the Committee
for Medicinal Products for Human Use (CHMP), the scientific advisory
committee of the European...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3290</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3290</guid>
				<pubDate>Fri, 26 Jun 2009 13:38:00 +0000</pubDate>
			</item>
					<item>
				<title>ONGLYZA(TM) (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes</title>
				<description>PARIS and LONDON, June 25 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (LSE: AZN) today
announced that their marketing authorisation application for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3283</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3283</guid>
				<pubDate>Thu, 25 Jun 2009 17:31:00 +0000</pubDate>
			</item>
					<item>
				<title>Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus</title>
				<description>SAN DIEGO, June 9 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new distribution
agreements for its VerifyNow(R) System in both Israel and Cyprus.
Medtechnica, Ltd. will oversee...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3183</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3183</guid>
				<pubDate>Tue, 09 Jun 2009 14:35:00 +0000</pubDate>
			</item>
					<item>
				<title>Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier</title>
				<description>NOVATO, California, June 9 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (&quot;Raptor&quot; or the &quot;Company&quot;) (OTC Bulletin
Board: RPTP), today announced that it has entered a collaboration and
licensing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3182</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3182</guid>
				<pubDate>Tue, 09 Jun 2009 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany</title>
				<description>NAPA, California, June 8 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3177</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3177</guid>
				<pubDate>Mon, 08 Jun 2009 14:30:00 +0000</pubDate>
			</item>
					<item>
				<title>ZigBee Selected by Continua Health Alliance for Next Generation Guidelines</title>
				<description>SAN RAMON, California, June 8 /PRNewswire/ -- The ZigBee(R) Alliance announced today that the Continua Health Alliance
has endorsed ZigBee Health Care as Continua&#039;s new low power local area
network...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3176</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3176</guid>
				<pubDate>Mon, 08 Jun 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity and Integromics Offer Integration for Comprehensive Genomics Analysis</title>
				<description>REDWOOD CITY, California, June 2 /PRNewswire/ -- Integromics, S.L. and Ingenuity Systems announced the integration of
RealTime StatMiner(R) and Integromics Biomarker Discovery(TM) (IBD) for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3148</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3148</guid>
				<pubDate>Tue, 02 Jun 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Abbott &amp;amp; BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays</title>
				<description>SAN RAMON, California, June 2 /PRNewswire/ -- BioGenex, a developer of innovative instruments and reagents for
automated slide based staining systems for molecular diagnostics, announced
today that...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3149</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3149</guid>
				<pubDate>Tue, 02 Jun 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria</title>
				<description>AMSTERDAM, May 28 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, announced today that the European Medicines
Agency has granted Orphan...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3122</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3122</guid>
				<pubDate>Thu, 28 May 2009 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Copan and POCARED Diagnostics Partner to Enhance the Use of Liquid Based Microbiology and Introduce the Next Generation Microbiology Systems</title>
				<description>BRESCIA, Italy, May 18 /PRNewswire/ -- Under the partnership, the two companies will enhance the use of liquid
based microbiology diagnostic products that incorporate Copan innovative
collection and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3064</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3064</guid>
				<pubDate>Mon, 18 May 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Alimentary Health&#039;s Probiotic Technology Launched Nationwide in the US</title>
				<description>CORK, Ireland, May 12 /PRNewswire/ -- Alimentary Health Ltd. (&quot;Alimentary Health&quot; or &quot;the Company&quot;),
the specialty gastrointestinal company, welcomes today&#039;s announcement from
its licensing partner...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3042</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3042</guid>
				<pubDate>Tue, 12 May 2009 16:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity Systems Announces Multi-Year Deal With AstraZeneca</title>
				<description>REDWOOD CITY, California, May 5 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, today announced a multi-year agreement with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3000</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3000</guid>
				<pubDate>Tue, 05 May 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union</title>
				<description>S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 /PRNewswire/ -- Bial-Portela &amp;amp; CA, S.A., (S. Mamede do Coronado, Portugal,
President &amp;amp; CEO Dr Luis Portela), and Eisai Europe Limited...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2956</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2956</guid>
				<pubDate>Tue, 28 Apr 2009 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis</title>
				<description>PRINCETON, New Jersey, April 8 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into a license agreement
with sanofi-aventis (EURONEXT: SAN and NYSE: SNY), providing the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2861</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2861</guid>
				<pubDate>Wed, 08 Apr 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services</title>
				<description>BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic
partnership with Roche to support discovery phase research efforts at Roche&#039;s
global research sites....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2846</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2846</guid>
				<pubDate>Mon, 06 Apr 2009 23:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Orcrist Bio Inc. Receives Approval From European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750</title>
				<description>CALGARY, Canada, April 6 /PRNewswire/ -- Orcrist Bio Inc. (ORC) a biotechnology company developing stem
cell-mobilizing pharmaceuticals, announced today the approval of its Phase I,
open-label,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2843</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2843</guid>
				<pubDate>Mon, 06 Apr 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD</title>
				<description>PHILADELPHIA, March 31 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced a co-promotion agreement with
GlaxoSmithKline plc (NYSE:...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2808</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2808</guid>
				<pubDate>Tue, 31 Mar 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation</title>
				<description>MAIDENHEAD, England, March 11 /PRNewswire/ -- Wyeth announced today it has received a positive decision from the
European Commission for a variation of the marketing authorisation for
ReFacto...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2700</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2700</guid>
				<pubDate>Wed, 11 Mar 2009 16:17:00 +0000</pubDate>
			</item>
					<item>
				<title>Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)</title>
				<description>NEW YORK, March 3 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a
biopharmaceutical company focused on development of disease-modifying
therapeutic agents for Alzheimer&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2657</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2657</guid>
				<pubDate>Tue, 03 Mar 2009 10:50:00 +0000</pubDate>
			</item>
					<item>
				<title>Motorcycle Cancer Risk: Motorcycle Cop Cancer Concern from ELF EMFs Penetrating Motorcycle Seats</title>
				<description>MISSISSAUGA, Ontario, March 3 /PRNewswire/ -- A book entitled Motorcycle Cancer? is sending a shock wave through the
motorcycle industry worldwide. &quot;Motorcycle seat extremely low...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2654</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2654</guid>
				<pubDate>Tue, 03 Mar 2009 10:07:00 +0000</pubDate>
			</item>
					<item>
				<title>Endo Licenses Novel Pain Therapy From Grunenthal</title>
				<description>AACHEN, Germany, March 2 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced that it has licensed from
Grunenthal the exclusive rights to develop and market the investigational
drug...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2648</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2648</guid>
				<pubDate>Mon, 02 Mar 2009 17:40:00 +0000</pubDate>
			</item>
					<item>
				<title>Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company</title>
				<description>MANCHESTER, England, March 2 /PRNewswire/ -- Epistem Plc (LSE:EHP) the UK biotechnology and research
services company announced today that they have signed a research and
development collaboration...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640</guid>
				<pubDate>Mon, 02 Mar 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>The MDS Foundation Welcomes Availability of VIDAZA (Azacitidine) in the UK and Ireland</title>
				<description>LONDON, March 2 /PRNewswire/ -- The Myelodysplastic Syndromes (MDS) Foundation is pleased to support the
licensed use of VIDAZA in the United Kingdom and Ireland to treat a subset of
patients with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2638</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2638</guid>
				<pubDate>Mon, 02 Mar 2009 00:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe</title>
				<description>PARIS, January 24 /PRNewswire/ -- The European Commission has granted marketing authorisation for Servier&#039;s
Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant
for the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2609</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2609</guid>
				<pubDate>Tue, 24 Feb 2009 17:51:00 +0000</pubDate>
			</item>
					<item>
				<title>PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova&#039;s Enantiomers of DOTAP Chloride in Immunotherapies</title>
				<description>INDIANAPOLIS, February 24 /PRNewswire/ -- PDS Biotechnology today announced that the company has obtained an
exclusive license from Merck Eprova AG to utilize Merck Eprova&#039;s proprietary
chiral lipid...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2607</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2607</guid>
				<pubDate>Tue, 24 Feb 2009 16:58:00 +0000</pubDate>
			</item>
					<item>
				<title>European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)</title>
				<description>GENEVA, Switzerland, February 19 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that the European Medicines Agency (EMEA) has recommended to
the European...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2581</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2581</guid>
				<pubDate>Thu, 19 Feb 2009 17:49:00 +0000</pubDate>
			</item>
					<item>
				<title>European Commisssion Grants Ferring Pharmaceuticals Approval of FIRMAGON(R) (Degarelix) for Treatment of Prostate Cancer</title>
				<description>SAINT-PREX, Switzerland, February 19 /PRNewswire/ -- Ferring Pharmaceuticals announced today that it has received marketing 
authorisation from the European Commission, for FIRMAGON(R) (degarelix), a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2580</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2580</guid>
				<pubDate>Thu, 19 Feb 2009 15:47:00 +0000</pubDate>
			</item>
					<item>
				<title>Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)</title>
				<description>LONDON, February 19 /PRNewswire/ -- Eisai Europe Ltd (London; Chairman &amp;amp; CEO Yutaka Tsuchiya), the
European subsidiary of Eisai Co., Ltd. (Tokyo, President &amp;amp; CEO: Haruo Naito),
and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2579</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2579</guid>
				<pubDate>Thu, 19 Feb 2009 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Now Approved in the European Union for Treatment of Patients With Diabetes</title>
				<description>WARREN, New Jersey, February 11 /PRNewswire/ -- The CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent has received
CE marking within the European Union (EU) for treatment of patients...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2542</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2542</guid>
				<pubDate>Wed, 11 Feb 2009 17:02:00 +0000</pubDate>
			</item>
					<item>
				<title>Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions</title>
				<description>LAUSANNE, Switzerland, and PARIS, February 9 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical
development specialist that focuses on serious medical conditions...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2528</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2528</guid>
				<pubDate>Mon, 09 Feb 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott&#039;s Architect(R) Analyzers</title>
				<description>MALVERN, Pennsylvania and ABBOTT PARK, Illinois, January 27 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to
develop a new ovarian cancer test for use on...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2480</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2480</guid>
				<pubDate>Tue, 27 Jan 2009 15:14:00 +0000</pubDate>
			</item>
					<item>
				<title>blinkx Signs Premiere Fitness Partners to Help Users Find the Perfect Health Regimen and Routine</title>
				<description>SAN FRANCISCO, January 20 /PRNewswire/ -- blinkx, the world&#039;s largest and most advanced video search engine, today
announced new partnerships with Studio 4 Fitness, Diet.com, BodyArchitect.tv,
and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2439</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2439</guid>
				<pubDate>Tue, 20 Jan 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Orthomimetics Secures CE Mark Approval for Chondromimetic</title>
				<description>CAMBRIDGE, England, January 14 /PRNewswire/ -- This approval enables the company to market its line of bioresorbable
implants for bone and/or soft tissue repair in the EU. Orthomimetics&#039; family
of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2406</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2406</guid>
				<pubDate>Wed, 14 Jan 2009 11:03:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis</title>
				<description>GENEVA, Switzerland, January 13 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced 
today the signature of a research, development and commercialization agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2396</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2396</guid>
				<pubDate>Tue, 13 Jan 2009 09:02:00 +0000</pubDate>
			</item>
					<item>
				<title>ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell</title>
				<description>LEIDEN, The Netherlands, January 13 /PRNewswire/ -- ProFibrix B.V., today announced that it has concluded a
commercial license agreement with Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss
Exchange:...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2394</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2394</guid>
				<pubDate>Tue, 13 Jan 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline</title>
				<description>CAMBRIDGE, England, January 12 /PRNewswire/ -- Biotica Technology Limited, a privately-held biotechnology
company, announces a significant Collaboration and License Agreement with
GlaxoSmithKline to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382</guid>
				<pubDate>Mon, 12 Jan 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Sun Pharma Receives USFDA Approvals for 4 Generic Products</title>
				<description>MUMBAI, India, January 7 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,
Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that together with
its subsidiaries, it has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2368</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2368</guid>
				<pubDate>Wed, 07 Jan 2009 14:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Concateno Team With Merck to Bring Road-Side Drug Testing to India</title>
				<description>LONDON, December 17 /PRNewswire/ -- Concateno plc, Europe&#039;s largest provider of drug and alcohol
testing programmes, has today announced an exclusive arrangement with Merck
Specialities Private...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2321</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2321</guid>
				<pubDate>Wed, 17 Dec 2008 16:24:00 +0000</pubDate>
			</item>
					<item>
				<title>Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test</title>
				<description>MALVERN, Pennsylvania and BASEL, Switzerland, December 16 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Roche Diagnostics announced today a
worldwide license and supply agreement for the HE4...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2315</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2315</guid>
				<pubDate>Tue, 16 Dec 2008 15:39:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology</title>
				<description>NAPA, California, December 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2304</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2304</guid>
				<pubDate>Mon, 15 Dec 2008 13:55:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization</title>
				<description>PRINCETON, New Jersey, December 8 /PRNewswire/ -- BioWa, Inc., announced today that it licensed to GlaxoSmithKline (NYSE:
GSK) its POTELLIGENT(R) Technology for use in developing and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2270</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2270</guid>
				<pubDate>Mon, 08 Dec 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>MGuard(TM) Coronary Stent System Approved in Israel</title>
				<description>TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced that the MGuard(TM) coronary stent system has
been approved for use in Israel by the Israeli Ministry of Health.

    The...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2268</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2268</guid>
				<pubDate>Mon, 08 Dec 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Commission Approval of New Indication for Roche&#039;s Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure</title>
				<description>BASEL, Switzerland, December 4 /PRNewswire/ -- Roche announced today that the European Commission has approved
Pegasys(R) (peginterferon alfa-2a (40 KD)) plus Copegus(R) (ribavirin) for
the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2253</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2253</guid>
				<pubDate>Thu, 04 Dec 2008 14:40:00 +0000</pubDate>
			</item>
					<item>
				<title>The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom</title>
				<description>DERBYSHIRE, England and MOUNTAIN VIEW, California, USA, December 2 /PRNewswire/ -- Attainia and The National Health Service Supply Chain today announced
they will deploy Attainia&#039;s suite of web-based...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2232</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2232</guid>
				<pubDate>Tue, 02 Dec 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Agency for the Evaluation of Medicinal Products Recommends Suspension of Marketing Authorisation for IONSYS(R)</title>
				<description>BEERSE, Belgium, November 20 /PRNewswire/ -- Janssen-Cilag International NV announced today that the Committee for
Medicinal Products for Human Use (CHMP) of the European Medicines Agency 
(EMEA) has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2178</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2178</guid>
				<pubDate>Thu, 20 Nov 2008 17:20:00 +0000</pubDate>
			</item>
					<item>
				<title>Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research</title>
				<description>CAMBRIDGE, England, November 11 /PRNewswire/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the
commercialisation of stem cells and stem cell technologies, announces that it
has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2098</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2098</guid>
				<pubDate>Tue, 11 Nov 2008 08:41:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono&#039;s US Affiliate EMD Serono, Inc. and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States</title>
				<description>GENEVA, Switzerland, October 29 /PRNewswire/ -- Merck Serono announced today that its US affiliate EMD Serono,
Inc. and Theratechnologies (TSX:TH) have entered into a collaboration and
licensing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2012</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2012</guid>
				<pubDate>Wed, 29 Oct 2008 12:56:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa Announces License of Biowa&#039;s Potelligent(R) Technology to KaloBios Pharmaceuticals</title>
				<description>PRINCETON, New Jersey, October 28 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into an agreement with
KaloBios Pharmaceuticals, Inc., under which BioWa licenses to KaloBios...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1998</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1998</guid>
				<pubDate>Tue, 28 Oct 2008 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>World&#039;s First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada</title>
				<description>BELLEVILLE, Canada, October 27 /PRNewswire/ -- Bioniche Life Sciences Inc. (TSX: BNC), a research-based,
technology-driven Canadian biopharmaceutical company, today announced that
Econiche(TM), the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1988</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1988</guid>
				<pubDate>Mon, 27 Oct 2008 13:15:00 +0000</pubDate>
			</item>
					<item>
				<title>Sanofi-aventis is Complying With the EMEA&#039;s Recommendation to Temporarily Suspend the Marketing Authorisation of Acomplia(R) in Obese and Overweight Patients</title>
				<description>PARIS, October 23 /PRNewswire/ -- Sanofi-aventis announced today that the European Medicines
Agency (EMEA) has recommended to the European Commission (EC) the temporary
suspension of the marketing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1975</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1975</guid>
				<pubDate>Thu, 23 Oct 2008 17:18:00 +0000</pubDate>
			</item>
					<item>
				<title>Enigma Diagnostics Announces Patent Licence With Applied Biosystems</title>
				<description>PORTON DOWN, England, October 22 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced today that it has signed a third...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1957</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1957</guid>
				<pubDate>Wed, 22 Oct 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>PHM International Expands Brand in Macedonia</title>
				<description>SEBASTIAN, Florida and SKOPJE, Macedonia, October 21 /PRNewswire/ -- PHM International, Inc., a worldwide healthcare consultancy, and Dr.
Venko Filipce announce the signing of a Letter of Intent...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1949</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1949</guid>
				<pubDate>Tue, 21 Oct 2008 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa Licenses POTELLIGENT(R) Technology to CSL Limited</title>
				<description>PRINCETON, New Jersey, October 9 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into a license agreement
with CSL Limited, providing CSL with access to BioWa&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1890</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1890</guid>
				<pubDate>Thu, 09 Oct 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer&#039;s Patents and Patent Applications</title>
				<description>NEW YORK, October 8 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a 
biopharmaceutical company focused on development of disease-modifying 
therapeutic agents for the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1878</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1878</guid>
				<pubDate>Wed, 08 Oct 2008 10:45:00 +0000</pubDate>
			</item>
					<item>
				<title>ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal</title>
				<description>EMERYVILLE, California, October 7 /PRNewswire/ -- ProGenTech Limited, a life sciences &amp;amp; diagnostics company based in
Shanghai, China and Emeryville, CA has signed a licensing agreement with
Human...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1871</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1871</guid>
				<pubDate>Tue, 07 Oct 2008 08:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.</title>
				<description>SCHLIEREN, Switzerland, LAUSANNE, Switzerland and SAN DIEGO, October 6 /PRNewswire/ -- Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and
ChemDiv Inc. (ChemDiv), a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1862</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1862</guid>
				<pubDate>Mon, 06 Oct 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Bayer&#039;s Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence</title>
				<description>NEWBURY, England, October 2 /PRNewswire/ -- A new drug launched today could help in the fight against what
experts and campaigners are calling a &#039;major patient safety issue&#039;(1) - the
prevention of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1842</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1842</guid>
				<pubDate>Thu, 02 Oct 2008 11:35:00 +0000</pubDate>
			</item>
					<item>
				<title>Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board</title>
				<description>RICHMOND, California, October 1 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in the development of new
proprietary fluorescent metal-lanthanide technology for use in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1829</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1829</guid>
				<pubDate>Wed, 01 Oct 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels</title>
				<description>OR AKIVA, Israel, September 30 /PRNewswire/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with
research, development, manufacturing and marketing of heterologous tissue
covered stents,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1827</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1827</guid>
				<pubDate>Tue, 30 Sep 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Sun Pharmaceutical Announces USFDA Approval to Market Generic Paraplatin(R) Injection</title>
				<description>MUMBAI, India, September 23 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an
approval for the Abbreviated New Drug Application (ANDA) to market...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1788</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1788</guid>
				<pubDate>Tue, 23 Sep 2008 15:56:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Obtains License to Amgen&#039;s GDNF Gene to Develop Treatment for Parkinson&#039;s Disease with AMT&#039;s Proprietary Gene Therapy Platform</title>
				<description>AMSTERDAM, The Netherlands, September 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced that it obtained a license
from...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1750</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1750</guid>
				<pubDate>Thu, 18 Sep 2008 07:08:00 +0000</pubDate>
			</item>
					<item>
				<title>Ekkyo Continues its Development With the CE Marking of EkkyLite(R)</title>
				<description>MARSEILLES, France, September 16 /PRNewswire/ -- Ekkyo a photomedicine company, which develops first-in-class
laser-based systems for skin scar prevention and reduction, announces that
EkkyLite(R) a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1727</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1727</guid>
				<pubDate>Tue, 16 Sep 2008 09:50:00 +0000</pubDate>
			</item>
					<item>
				<title>Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in Europe</title>
				<description>GENEVA, Switzerland, September 10 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that Glucophage(R) Powder for Oral Solution in Sachet
(metformin...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1697</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1697</guid>
				<pubDate>Wed, 10 Sep 2008 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>GNC Continues European Expansion Through Exclusive Online Distribution Agreement with Active Nutrition International for Sales of Sports Nutrition Products in Sweden, Finland, Denmark &amp;amp; Norway</title>
				<description>PITTSBURGH, September 3 /PRNewswire/ -- General Nutrition Centers, Inc., the largest global specialty retailer of
nutritional supplements, today announced another step in its continuing
expansion in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1615</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1615</guid>
				<pubDate>Wed, 03 Sep 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate</title>
				<description>KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic&#039;s US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1510</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1510</guid>
				<pubDate>Wed, 13 Aug 2008 08:37:00 +0000</pubDate>
			</item>
					<item>
				<title>Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate</title>
				<description>KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic&#039;s US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1527</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1527</guid>
				<pubDate>Wed, 13 Aug 2008 08:37:00 +0000</pubDate>
			</item>
					<item>
				<title>Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care</title>
				<description>MOUNTAIN VIEW, California, August 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, announced today that it has entered into...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1505</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1505</guid>
				<pubDate>Tue, 12 Aug 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care</title>
				<description>MOUNTAIN VIEW, California, August 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, announced today that it has entered into...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1522</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1522</guid>
				<pubDate>Tue, 12 Aug 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ImmunoVaccine Technologies Broadens Its Patent Protection to Japan</title>
				<description>HALIFAX, Canada, August 5 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, 
today announced receipt of patent approval from the Japanese Patent Office 
for its...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1486</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1486</guid>
				<pubDate>Tue, 05 Aug 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cytochroma and Mitsubishi Tanabe Form Partnership for Chronic Kidney Disease Therapies in U.S. and Asia</title>
				<description>MARKHAM, Canada and OSAKA, Japan, July 30 /PRNewswire/ -- Cytochroma and Mitsubishi Tanabe Pharma Corporation (&quot;MTPC&quot;)
today announced that the companies have signed a license agreement under
which...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1467</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1467</guid>
				<pubDate>Wed, 30 Jul 2008 13:09:00 +0000</pubDate>
			</item>
					<item>
				<title>Max Planck Society Awards Exclusive License to Dafra Pharma R&amp;amp;D to Develop a Drug Against Leishmaniasis</title>
				<description>TURNHOUT, Belgium, July 16 /PRNewswire/ -- Max Planck Innovation, the technology transfer agency of the
Max Planck Society based in Munich, Germany and Dafra Pharma R&amp;amp;D, a Belgian
research...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1401</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1401</guid>
				<pubDate>Wed, 16 Jul 2008 12:26:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa and Medarex Announce License of BioWa&#039;s COMPLEGENT(TM) Technology</title>
				<description>PRINCETON, New Jersey, July 16 /PRNewswire/ -- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they
have entered into a license agreement which provides Medarex with the first
ever...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1399</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1399</guid>
				<pubDate>Wed, 16 Jul 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Jerini Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE</title>
				<description>BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, notes that Jerini AG (FSE:JI4) has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1396</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1396</guid>
				<pubDate>Tue, 15 Jul 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>RiderSaver(TM) EMF Seat Shield Reduces Motorcycle Cancer Concern</title>
				<description>MISSISSAUGA, Ontario, July 11 /PRNewswire/ -- A new motorcycle seat accessory provides peace of mind for riders
concerned about cancer risk. &quot;It&#039;s not just about cancer,&quot; says Canadian
author and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1379</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1379</guid>
				<pubDate>Fri, 11 Jul 2008 08:08:00 +0000</pubDate>
			</item>
					<item>
				<title>Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets</title>
				<description>BANNOCKBURN, Illinois, July 10 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech
solutions company today announced it has entered into an agreement with
pharmexx...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1374</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1374</guid>
				<pubDate>Thu, 10 Jul 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis</title>
				<description>MAIDENHEAD, England, July 9 /PRNewswire/ -- The European Commission announced today a new 50 mg Enbrel(R)
(etanercept) once weekly dosage regimen as an alternative to the currently
approved 25 mg...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1364</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1364</guid>
				<pubDate>Wed, 09 Jul 2008 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients</title>
				<description>MAIDENHEAD, England, July 7 /PRNewswire/ -- Wyeth Pharmaceuticals, today 3rd July, announced that it has received
EMEA marketing approval for Relistor(TM) (methylnaltrexone bromide)
subcutaneous...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1356</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1356</guid>
				<pubDate>Mon, 07 Jul 2008 18:56:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited</title>
				<description>NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343</guid>
				<pubDate>Thu, 03 Jul 2008 14:30:00 +0000</pubDate>
			</item>
					<item>
				<title>MS Drug Development Agreement Based on WEHI&#039;s Medicinal Chemistry</title>
				<description>MELBOURNE, Australia, July 2 /PRNewswire/ -- Research conducted at The Walter and Eliza Hall Institute (WEHI) has
contributed significantly to a major licensing agreement signed between
Australian...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1333</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1333</guid>
				<pubDate>Wed, 02 Jul 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek&#039;s life&#039;sDHA(TM)</title>
				<description>COLUMBIA, Maryland, June 26 /PRNewswire/ -- Martek Biosciences (Nasdaq: MATK) announced today that life&#039;sDHA(TM), its
patented, vegetarian form of DHA-omega 3 essential for infant brain and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1302</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1302</guid>
				<pubDate>Thu, 26 Jun 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) as a Treatment Option for Eligible Chronic Hepatitis B Patients</title>
				<description>UXBRIDGE, England, June 25 /PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence)
has announced today, in its Final Appraisal Determination (FAD), that
Baraclude(R) (entecavir)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1284</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1284</guid>
				<pubDate>Tue, 24 Jun 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pinnacle Biologics Announces Contract With Chiltern</title>
				<description>ROCKVILLE, Maryland, June 24 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech
solutions company, today announced it has entered into an agreement with
Chiltern...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1272</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1272</guid>
				<pubDate>Tue, 24 Jun 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cardium&#039;s InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems</title>
				<description>SAN DIEGO, June 19 /PRNewswire/ -- Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool
Therapies announced today that InnerCool has entered into a exclusive
commercialization agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1251</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1251</guid>
				<pubDate>Thu, 19 Jun 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement</title>
				<description>GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that a Development and Licensing Agreement with Bionomics
(ASX: BNO) was signed, under...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237</guid>
				<pubDate>Wed, 18 Jun 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody</title>
				<description>LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent
International AB (Nordic Exchange: BINV) announce that they have...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1232</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1232</guid>
				<pubDate>Wed, 18 Jun 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group</title>
				<description>ROCKVILLE, Maryland, June 17 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech
solutions company, today announced it has entered into a logistic service
agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1220</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1220</guid>
				<pubDate>Tue, 17 Jun 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>BioWa Licenses POTELLIGENT(R) Technology to Major Pharmaceutical Company for Use in Antibody Research and Development</title>
				<description>PRINCETON, New Jersey, June 11 /PRNewswire/ -- BioWa, Inc. announced today that it has licensed its POTELLIGENT(R)
Technology to Novartis for the development of antibody therapeutics with
enhanced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1185</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1185</guid>
				<pubDate>Wed, 11 Jun 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy</title>
				<description>AMSTERDAM, The Netherlands, May 22 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field 
of human gene therapy, today announced that it obtained a license from La...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1055</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1055</guid>
				<pubDate>Thu, 22 May 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.</title>
				<description>NEW YORK, May 19 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a
biopharmaceutical company focused on development of disease-modifying
therapeutic agents for the treatment...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1029</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1029</guid>
				<pubDate>Mon, 19 May 2008 12:45:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek PLC Reports First Quarter 2008 Financial Results</title>
				<description>NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1010</guid>
				<pubDate>Thu, 15 May 2008 22:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare</title>
				<description>SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new
company dedicated to developing and commercializing targeted oral cancer
drugs....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/944</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/944</guid>
				<pubDate>Wed, 07 May 2008 16:55:00 +0000</pubDate>
			</item>
					<item>
				<title>Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug</title>
				<description>TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada&#039;s largest generic pharmaceutical company has 
successfully bid and been awarded a tender from the Rwandan Government for 
the life saving triple...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/942</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/942</guid>
				<pubDate>Wed, 07 May 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Astellas&#039; Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections</title>
				<description>STAINES, England, May 7 /PRNewswire/ -- The European Medicines Agency (EMEA) has announced the marketing
authorisation of Mycamine(R), Astellas Pharma Europe&#039;s treatment for invasive
candidiasis,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/939</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/939</guid>
				<pubDate>Wed, 07 May 2008 12:24:00 +0000</pubDate>
			</item>
					<item>
				<title>Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development</title>
				<description>TORONTO, May 6 /PRNewswire/ -- Dalton Pharma Services, a privately owned Canadian pharmaceutical
services provider, and Thermo Fisher Scientific have entered into an
agreement under which Dalton will...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/930</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/930</guid>
				<pubDate>Tue, 06 May 2008 16:12:00 +0000</pubDate>
			</item>
					<item>
				<title>Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate</title>
				<description>REHOVOT, Israel and JERSEY CITY, New Jersey, April 28 /PRNewswire/ -- Rosetta Genomics (Nasdaq:ROSG), a leading developer of
microRNA-based diagnostics and therapeutics, announced today that it...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/885</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/885</guid>
				<pubDate>Mon, 28 Apr 2008 13:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Smiths Medical to Promote and Distribute Abbott&#039;s FreeStyle Navigator Continuous Glucose Monitoring System</title>
				<description>ABBOTT PARK, Illinois and ST. PAUL, Minnesota, April 22 /PRNewswire/ -- Smiths Medical MD will promote and distribute Abbott&#039;s FreeStyle
Navigator Continuous Glucose Monitoring System...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/833</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/833</guid>
				<pubDate>Tue, 22 Apr 2008 13:46:00 +0000</pubDate>
			</item>
					<item>
				<title>CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label</title>
				<description>ATLANTA, April 17 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue
processing company, announced today that it has signed an exclusive
three-year agreement with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/814</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/814</guid>
				<pubDate>Thu, 17 Apr 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek PLC Announces Riley-Nacht LLC - Leading Global Brand Development Company to Direct Dermatological Product Marketing Program</title>
				<description>NAPA, California, April 17 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/816</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/816</guid>
				<pubDate>Thu, 17 Apr 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation</title>
				<description>RALEIGH, North Carolina, April 16 /PRNewswire/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today that Surgi-Vision,
Inc., a privately held company of which DARA Biosciences owns...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/810</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/810</guid>
				<pubDate>Wed, 16 Apr 2008 21:44:00 +0000</pubDate>
			</item>
					<item>
				<title>Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA</title>
				<description>AMSTERDAM, April 15 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announced today that the U.S.
Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan
Drug Designation...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/796</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/796</guid>
				<pubDate>Tue, 15 Apr 2008 11:28:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis</title>
				<description>REDWOOD CITY, California, April 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, and Pfizer Pharmaceuticals, Inc. (NYSE: PFE),...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/795</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/795</guid>
				<pubDate>Tue, 15 Apr 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission</title>
				<description>INGELHEIM, Germany, April 14 /PRNewswire/ -- Boehringer Ingelheim today announced that the European Commission has
granted marketing authorisation of the new powerful strength of their fixed
dose...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/789</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/789</guid>
				<pubDate>Mon, 14 Apr 2008 16:47:00 +0000</pubDate>
			</item>
					<item>
				<title>Roche Diagnostics Expands Availability of HCV Immunoassay</title>
				<description>ROTKREUZ, Switzerland, April 8 /PRNewswire/ -- Roche Diagnostics announced today that the Elecsys Anti-HCV (Hepatitis C
Virus) assay has received regulatory approval in Europe for the E 170
analyzer...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/745</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/745</guid>
				<pubDate>Tue, 08 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission</title>
				<description>INGELHEIM, Germany, March 27 /PRNewswire/ -- Boehringer Ingelheim today announced that the European Commission has 
granted marketing authorisation of the novel, oral direct thrombin 
inhibitor,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/624</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/624</guid>
				<pubDate>Thu, 27 Mar 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert</title>
				<description>DALLAS, March 13 /PRNewswire/ --     
    - Entrust IdentityGuard OTP tokens secure access to corporate resources
for remote workforce

</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/696</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/696</guid>
				<pubDate>Thu, 13 Mar 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion</title>
				<description>ANDOVER, Massachusetts and BANBURY, England, March 10 /PRNewswire/ --     
    IBA Health Group company iSOFT has today signed an agreement with
US-based Sentillion to become its first healthcare...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/676</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/676</guid>
				<pubDate>Mon, 10 Mar 2008 14:11:00 +0000</pubDate>
			</item>
					<item>
				<title>Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)</title>
				<description>LAUSANNE, Switzerland, March 7 /PRNewswire/ --     
    Galderma Pharma, S.A. announces an agreement with ZARS Pharma, Inc.
giving Galderma exclusive rights for all markets outside the USA and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/672</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/672</guid>
				<pubDate>Fri, 07 Mar 2008 18:09:00 +0000</pubDate>
			</item>
					<item>
				<title>Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response</title>
				<description>DES PLAINES, Illinois, March 7 /PRNewswire/ --     
    - Abbott&#039;s FISH Technology Provides Analytical Tool with Potential to 
Assess Clinical Response to Lung Cancer Treatment in Patients with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/670</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/670</guid>
				<pubDate>Fri, 07 Mar 2008 14:03:00 +0000</pubDate>
			</item>
					<item>
				<title>Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400</title>
				<description>SANTA CLARA, California, March 7 /PRNewswire/ --     
    Finesse Solutions, LLC, a manufacturer of measurement and control
solutions for life sciences process applications, and Nova...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/667</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/667</guid>
				<pubDate>Fri, 07 Mar 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical</title>
				<description>AACHEN, Germany, January 30 /PRNewswire/ -- mNEMOSCIENCE GmbH, the pioneer in the design, manufacture and
commercialization of innovative, biocompatible shape memory polymers
(BIO-SMP(TM)), today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/554</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/554</guid>
				<pubDate>Wed, 30 Jan 2008 14:00:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/newsmlrss/275/Licensing_Marketing_Agreements" rel="self" type="application/rss+xml" />
	</channel>
</rss>
